Newsroom

Sorted by: Latest

-

OMERS and Blackstone-Backed Transmission Developers Form Partnership to Pursue Toronto Third Line

TORONTO--(BUSINESS WIRE)--OMERS and Transmission Developers Infrastructure - Canada Co. (“TDI”), a Blackstone portfolio company, today announced that they have formed a partnership to pursue the Independent Electricity System Operator’s (“IESO”) upcoming Toronto Third Line (“TTL”) procurement. The Toronto Third Line is an important project designed to support the energy future of Canada’s largest city by delivering a strengthened supply of clean, reliable, and affordable electricity, delivered...
-

Finite State Ranked Number 371 Fastest-Growing Company in North America on the 2026 Deloitte Technology Fast 500™

COLUMBUS, Ohio--(BUSINESS WIRE)--Finite State, a leader in product security and software supply chain risk management, today announced that it ranked number 371 on the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing tech companies in North America, now in its 32nd year. Finite State grew 159% during 2022 to 2025. As connected products become more complex and software supply chain risks continue to mount, manufacturers are under increasing pressure to know what’s inside their...
-

Jumio Trust Snapshot: Who’s Willing to Share Their Identity with Your Business?

SUNNYVALE, Calif.--(BUSINESS WIRE)--Jumio, the leading provider of AI-powered identity intelligence, today released new findings from its 2026 Online Identity Study, revealing a growing divide in consumer trust around the protection of their personal data, with respondents indicating they are significantly more comfortable sharing information with highly-regulated industries including banks and fintechs than other online platforms. “Consumers are open to sharing their personal data for verifica...
-

Summit Therapeutics Further Expands Ivonescimab Global Development Program with Phase III HARMONi-10 Study in Unresectable Stage III Non-Small Cell Lung Cancer

MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) today announced the initiation of a new global Phase III clinical trial of ivonescimab, an investigational, novel PD-1 x VEGF bispecific antibody, in non-small cell lung cancer (NSCLC). The study, HARMONi-10, will evaluate ivonescimab compared with durvalumab as consolidation therapy in patients with locally advanced, unresectable Stage III NSCLC who have not experienced disease progression following platinum-based concurrent chemo...
-

GLP-1 Users Influence What More than One in Five Adults in the Americas Eat and Drink, dunnhumby Finds

CINCINNATI--(BUSINESS WIRE)--GLP-1 users influence the eating and drinking habits of more than one in five adults in the Americas, according to a special edition of dunnhumby’s Consumer Trends Tracker released today. The report, “How GLP-1s Are Reshaping the Grocery Basket,” found that the share of consumers changing what they eat and drink because they or someone in their household uses a GLP-1 was highest in Brazil (33%) and the U.S. (31.7%) and lowest in Chile (10%). The study surveyed 8,500...
-

ACI Worldwide Appoints Robert Leibrock as Interim Chief Executive Officer

OMAHA, Neb.--(BUSINESS WIRE)--ACI Worldwide (NASDAQ: ACIW), an original innovator in global payments technology, today announced that its Board of Directors (the “Board”) has appointed Robert (“Bobby”) Leibrock, Chief Financial Officer, as Interim President and Chief Executive Officer, effective November 18, 2026. Mr. Leibrock will continue to serve as Chief Financial Officer while serving as Interim President and Chief Executive Officer. Mr. Leibrock succeeds Thomas Warsop, who has accepted a...
-

NewEdge Names Jessica McAnneny Burt Head of Strategic Initiatives

NEW YORK--(BUSINESS WIRE)--NewEdge Capital Group, LLC, a leading and growing wealth management firm supporting successful financial advisors nationwide, announced today that Jessica McAnneny Burt has joined the firm as Head of Strategic Initiatives. She reports to CEO James Jesse and is based in the firm’s Stamford, CT office. In this newly created role, Burt will work with leaders across NewEdge Wealth, NewEdge Advisors, NewEdge Family Office, NewEdge Investment Solutions and the firm’s shared...
-

Vertical Aerospace Appoints Jason Mudrick to Board of Directors

BRISTOL, England--(BUSINESS WIRE)--Vertical Aerospace (“Vertical” or the “Company”) (NYSE: EVTL), a global aerospace and technology company pioneering electric aviation, today announced the appointment of Jason Mudrick to its Board of Directors (the “Board”), effective November 17, 2026. Mr. Mudrick brings extensive experience in capital allocation, financing and strategic transactions, alongside a detailed understanding of Vertical and its strategy. He joins recently appointed Chair Fabrice Br...
-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...